Lixte Biotechnology

/Lixte Biotechnology

Follow-On Uplisting: Our common stock is currently quoted on the OTCQB Marketplace. under the symbol “LIXT”. On October 30, 2020, the last reported sale price of our common stock on the OTCQB was $1.12 per share, which giving effect to a one-for-six reverse split of our common stock to be effected prior to or upon the effective date of our registration statement, equates to $6.72 per share. However, in this prospectus, we assume that the price per share in this offering, on a post-split basis, will be in the range of $5.75 to $6.75, and we have used the midpoint of such range ($6.25 per share) for the assumptions set forth herein.

Secured By miniOrange